The Parkville Cancer Clinical Trials Unit coordinates cancer clinical trials across the Parkville Precinct.
- We have over 180 open and recruiting trials in solid cancers and haematology. See our list of open and recruiting trials
- We recruit 550 patients every year
- Our early drug development (EDD) program gives opportunities for patients to take part in first-in-human trials. See our list of open and recruiting EDD trials
- We have a dedicated treatment area, with high care treatment chairs and overnight beds
- Our Clinical Trials unit can assist with any questions from Monday to Friday, 9am – 2pm on (03) 8559 7456
We are Australia’s largest cancer clinical trials unit, with dedicated treatment area and facilities. Our 10 cancer stream teams specialise in haematology, solid cancers, theranostics and palliative care:
- Breast cancer
- Gynaecological cancers
- Head and neck cancer
- Lower gastro-intestinal cancer
- Lung cancer
- Melanoma and skin cancer
- Neuro-oncology
- Sarcoma
- Upper gastro-intestinal cancer
- Urological cancer
- Acute leukaemias
- Allogeneic bone marrow transplant
- Chronic myeloid leukaemia
- Hodgkin lymphoma and aggressive non-Hodgkin lymphoma
- Indolent non-Hodgkin lymphoma and T-cell lymphoproliferative disease
- Late effects and survivorship
- Multiple myeloma
- Myelodysplastic syndromes
- Non-malignant haematology
- Myeloproliferative neoplasms
Our early drug development team offers clinical trials that test new treatments sometimes for the first time in humans. These trials recruit many different cancer types.